1Dr. B. R. Ambedkar Centre for Biomedical Research (ACBR), University of Delhi (North Campus), Delhi, 110007 India.
4Current address: Department of Biotechnology, Indian Institute of Technology, Roorkee, 247667 India.
Antimicrob Resist Infect Control. 2018 Dec 7;7:150. doi: 10.1186/s13756-018-0444-8. eCollection 2018.
Hospital acquired infections (HAI) are principal threats to the patients of intensive care units. An increase in the antimicrobial resistance (AMR) observed in gram negative bacteria is a great challenge to deal with. HAI and AMR lead to prolonged hospitalization and additional doses of anti-microbial treatment affecting patient's fitness and finances. Present study was undertaken to determine the pathotypes, genetic diversity and the antimicrobial resistance of in isolates from the patients admitted to intensive care unit at a tertiary care hospital in Delhi, India.
isolates ( = 77) obtained from the blood culture of patients diagnosed with sepsis and the isolates ( = 71) from the stool culture of patients admitted in intensive care unit (ICU) but not diagnosed with sepsis were investigated for their pathotypes, adherence patterns and genetic diversity by Enterobacterial Repeated Intergenic Consensus-polymerase chain reaction (ERIC-PCR). A Kirby-Bauer Disc diffusion test and antimicrobial susceptibility assays were performed according to the Clinical and Laboratory Standards Institute (CLSI) guidelines. Extended-spectrum β-lactamase (ESBL) genes and sequence type 131 (ST131) clone were characterised genotypically by gene-specific PCRs.
Pathotypes analysis revealed 46 and 16% of the blood isolates were ETEC and EAEC respectively, in contrast to the fecal isolates wherein 22% of the isolates were ETEC and 28.5% were EAEC. EPEC, STEC and EIEC pathotypes were not detected in blood or fecal isolates. Of all the isolates studied, more than 90% of the blood and 70% of the fecal isolates were found to be resistant to cephalosporins. On the other hand, 68% of blood and 44% of the fecal isolates were found to be ESBL producers. Interestingly 83% of the blood isolates contained CTX-M15, whereas only 21% of them contained CTX-M9 genes. On the other hand CTX-M15 genes were found in 90% and CTX-M9 genes were found in 63% of the fecal isolates.
The antimicrobial resistant profile found in this study is alarming and poses a great threat to public health. Apparently an increased antimicrobial resistance to the extensively used cephalosporins is affecting an optimal drug therapy for patients. In addition, the presence of catheters, prolonged duration of stay in the hospital and poor hygienic conditions due to infrequent urination of the patient can lead to an additional vulnerability. Therefore continuous surveillance and rational use of antibiotics along with effective hygienic measures are urgently recommended in such settings.
医院获得性感染(HAI)是重症监护病房患者的主要威胁。革兰氏阴性菌中观察到的抗生素耐药性(AMR)增加是一个巨大的挑战。HAI 和 AMR 导致住院时间延长和额外剂量的抗菌治疗,影响患者的健康和财务状况。本研究旨在确定印度德里一家三级护理医院重症监护病房患者分离株的病原体、遗传多样性和抗生素耐药性。
从诊断为败血症的患者的血培养中获得的 77 株分离株和从未诊断为败血症但入住重症监护病房(ICU)的患者的粪便培养中获得的 71 株分离株,通过肠杆菌重复基因间一致性-聚合酶链反应(ERIC-PCR)检测其病原体、粘附模式和遗传多样性。根据临床和实验室标准协会(CLSI)指南进行 Kirby-Bauer 圆盘扩散试验和抗菌药物敏感性试验。通过基因特异性 PCR 对产超广谱β-内酰胺酶(ESBL)基因和 ST131 克隆进行基因分型。
病原体分析显示,血源分离株中 46%和 16%分别为 ETEC 和 EAEC,而粪便分离株中 22%为 ETEC,28.5%为 EAEC。未在血源或粪便分离株中检测到 EPEC、STEC 和 EIEC 病原体。在所研究的所有分离株中,超过 90%的血源和 70%的粪便分离株对头孢菌素耐药。另一方面,68%的血源和 44%的粪便分离株为 ESBL 产生者。有趣的是,83%的血源分离株含有 CTX-M15,而只有 21%含有 CTX-M9 基因。另一方面,CTX-M15 基因存在于 90%的粪便分离株中,CTX-M9 基因存在于 63%的粪便分离株中。
本研究发现的抗生素耐药谱令人震惊,对公众健康构成巨大威胁。显然,广泛使用的头孢菌素类药物的耐药性增加,影响了患者的最佳药物治疗。此外,由于患者排尿不畅,留置导管、住院时间延长和卫生条件差等因素会导致患者的易感性增加。因此,在这种情况下,建议持续监测、合理使用抗生素以及采取有效的卫生措施。